carbamates has been researched along with MS (Multiple Sclerosis) in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we show that oral dosing with SNJ-1945, a novel water-soluble calpain inhibitor, reduces experimental autoimmune encephalomyelitis clinical scores in vivo and has a two pronged effect via anti-inflammation and protection against neurodegeneration." | 5.40 | Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis. ( Azuma, M; Banik, NL; Beeson, C; Haque, A; Inoue, J; Smith, A; Trager, N; Wallace Iv, G, 2014) |
| "In recent years several new treatments have been introduced in neurology, sumatriptan in migraine, riluzole in amyotrophic lateral sclerosis, interferon-beta in multiple sclerosis and rivastigmine in Alzheimer's disease." | 4.80 | [New therapies in neurology, but who benefits?]. ( de Haan, RJ; Vermeulen, M, 1999) |
| " Here, we show that oral dosing with SNJ-1945, a novel water-soluble calpain inhibitor, reduces experimental autoimmune encephalomyelitis clinical scores in vivo and has a two pronged effect via anti-inflammation and protection against neurodegeneration." | 1.40 | Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis. ( Azuma, M; Banik, NL; Beeson, C; Haque, A; Inoue, J; Smith, A; Trager, N; Wallace Iv, G, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trager, N | 1 |
| Smith, A | 1 |
| Wallace Iv, G | 1 |
| Azuma, M | 2 |
| Inoue, J | 2 |
| Beeson, C | 1 |
| Haque, A | 1 |
| Banik, NL | 2 |
| Rosenberger, TA | 1 |
| Bernal-Chico, A | 1 |
| Canedo, M | 1 |
| Manterola, A | 1 |
| Victoria Sánchez-Gómez, M | 1 |
| Pérez-Samartín, A | 1 |
| Rodríguez-Puertas, R | 1 |
| Matute, C | 1 |
| Mato, S | 1 |
| Podbielska, M | 1 |
| Das, A | 1 |
| Smith, AW | 1 |
| Chauhan, A | 1 |
| Ray, SK | 1 |
| Nozaki, K | 1 |
| Hogan, EL | 1 |
| Chabwine, JN | 1 |
| Rossetti, AR | 1 |
| Hirt, L | 1 |
| Kuntzer, T | 1 |
| Schluep, M | 1 |
| Michel, P | 1 |
| Démonet, JF | 1 |
| du Pasquier, RA | 1 |
| Vingerhoets, FG | 1 |
| Parry, AM | 1 |
| Scott, RB | 1 |
| Palace, J | 1 |
| Smith, S | 1 |
| Matthews, PM | 1 |
| THIEMEYER, JS | 1 |
| Vermeulen, M | 1 |
| de Haan, RJ | 1 |
1 review available for carbamates and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
[New therapies in neurology, but who benefits?].
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antiviral Agents; Carbamates; Humans; Interferon-b | 1999 |
1 trial available for carbamates and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine.
Topics: Adult; Carbamates; Cholinesterase Inhibitors; Cognition; Double-Blind Method; Female; Humans; Image | 2003 |
6 other studies available for carbamates and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.
Topics: Animals; Blotting, Western; Calpain; Carbamates; Cell Proliferation; Cell Separation; Cysteine Prote | 2014 |
Targeting calpain-mediated proteolysis and peptide signaling as a strategy to reduce injury in multiple sclerosis.
Topics: Animals; Calpain; Carbamates; Cysteine Proteinase Inhibitors; Encephalomyelitis, Autoimmune, Experim | 2014 |
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo.
Topics: Amidohydrolases; Animals; Benzamides; Benzodioxoles; Cannabinoid Receptor Modulators; Carbamates; De | 2015 |
Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation.
Topics: Animals; Calpain; Carbamates; Cell Survival; Cysteine Proteinase Inhibitors; Dipeptides; Enzyme Acti | 2016 |
[Neurology].
Topics: Antibodies, Monoclonal; Anticonvulsants; Atrial Fibrillation; Carbamates; Chronic Disease; Deep Brai | 2012 |
Mephenesin carbamate in the treatment of multiple sclerosis.
Topics: Carbamates; Humans; Mephenesin; Multiple Sclerosis; Psychotherapy, Multiple | 1959 |